» Articles » PMID: 1337350

The Bactericidal Activity of Sparfloxacin

Overview
Date 1992 Nov 1
PMID 1337350
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Sparfloxacin was found to display a biphasic response against Escherichia coli, Staphylococcus aureus and Staphylococcus epidermidis in nutrient broth. Its optimum bactericidal concentration was found to be identical for all three species which contrasts with other clinically available fluoroquinolones that are more active against E. coli than against staphylococci. Bacterial protein and RNA synthesis as well as cell division were not found to be essential for all the lethality of sparfloxacin, which hence displays bactericidal mechanism B. However, sparfloxacin was unable to kill bacteria in absence of oxygen.

Citing Articles

The In Vitro Antimicrobial Susceptibility of sensu lato: Shedding Light on the Known Unknowns.

Hunfeld K, Kraiczy P, Norris D, Lohr B Pathogens. 2023; 12(10).

PMID: 37887720 PMC: 10609913. DOI: 10.3390/pathogens12101204.


Suppression of gyrase-mediated resistance by C7 aryl fluoroquinolones.

Malik M, Mustaev A, Schwanz H, Luan G, Shah N, Oppegard L Nucleic Acids Res. 2016; 44(7):3304-16.

PMID: 26984528 PMC: 4838383. DOI: 10.1093/nar/gkw161.


Quinolone-mediated bacterial death.

Drlica K, Malik M, Kerns R, Zhao X Antimicrob Agents Chemother. 2007; 52(2):385-92.

PMID: 17724149 PMC: 2224783. DOI: 10.1128/AAC.01617-06.


Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know.

Hunfeld K, Brade V Wien Klin Wochenschr. 2006; 118(21-22):659-68.

PMID: 17160604 DOI: 10.1007/s00508-006-0693-z.


In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi.

Kraiczy P, Weigand J, Wichelhaus T, Heisig P, Backes H, Schafer V Antimicrob Agents Chemother. 2001; 45(9):2486-94.

PMID: 11502519 PMC: 90682. DOI: 10.1128/AAC.45.9.2486-2494.2001.